Company intelligence / Profile preview

Salud Care

Roorkee, Uttarakhand, India

Ownership: Private
Development stage: Other

Overview

Salud Care has established itself as a global manufacturer and supplier of over 950 pharmaceutical drug combinations, with key strengths in cardiovascular, antidiabetic, and dermatology segments. It supplies both branded and generic medications, is PIC/S compliant, and distributes to over 50 countries; revenue has surpassed ₹100 crore annually. The company is preparing for an IPO in late 2025.

Therapeutic areas: ImmunologyEndocrinologyMetabolic DisordersInfectious DiseasesGastroenterologyDermatologyPulmonologyCardiovascularNeurology
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

1 asset

Saldan

Unknown

Partnerships

Exploring strategic manufacturing partnerships and equity investments in injectable manufacturing facilities

Beyond the preview

Go deeper on Salud Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salud Care.

Explore the full profile